DCT
3:15-cv-05982
Boehringer Ingelheim Pharma Inc v. HEC Pharm Co Ltd
General
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (01/14/21)
Patent Owner
NPE (L)
PACER3:15-cv-05982
Appeals19-1172
CourtD. New Jersey
Judge | Period | PO Win Rate |
|---|---|---|
-- | 70% |
Plaintiff
Party
Name | Ratings |
|---|---|
L3A | |
L3A | |
L3A | |
L4D | |
L4D | |
L3A | |
L3A | |
L3A | |
L1B |
Attorney
Name | Ratings |
|---|---|
L5B | |
L5D | |
L5E | |
L5E | |
L4D | |
L4E | |
L3D | |
L3D | |
L2D | |
L3B | |
L3B | |
L2C | |
L3C | |
L5A | |
L5B | |
L4A | |
L4D | |
L4D | |
L3B |
Defendant
Party
Name | Ratings |
|---|---|
L2E | |
L5A | |
L5A | |
L5A | |
L5E | |
L5E | |
L5E | |
L5E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L3D | |
L3D | |
L3D | |
L3E | |
L3E | |
L3E | |
L2E | |
L2E | |
L2E | |
L1C | |
L1D | |
L1D |
Attorney
Name | Ratings |
|---|---|
L5B | |
L5D | |
L5E | |
L5E | |
L4D | |
L3D | |
L4B | |
L5D | |
L4B | |
L4D | |
L4B | |
L5D | |
L4B | |
L5E | |
L4B | |
L4B | |
L4E | |
L3C | |
L4B | |
L5D | |
L5E | |
L4B | |
L4C | |
L4D | |
L4D | |
L4D | |
L4E | |
L2D | |
---- -- | |
L4C | |
L5B | |
L4E | |
L5E | |
L4E | |
L3C | |
L3C | |
L3D | |
L4E | |
L1C | |
L1D | |
L1E | |
---- -- | |
Connell Foley LLPLocal | L3A |
L4A | |
L3B | |
L2B | |
L3B | |
L5E | |
---- -- | |
L3C | |
L5C | |
L4C | |
L3C | |
L5D | |
L5E | |
L4C | |
L3D | |
Patunas TarantinoLocal | L3E |
L3E | |
L3E | |
SaiberLocal | L3E |
L4E | |
L4E | |
L2B | |
L3E | |
L4D | |
L3D | |
L3D | |
L3E | |
L3E | |
L4E | |
L4E | |
Hill Wallack LLPLocal | L3E |
L3E | |
L3E | |
L3E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L4C | |
L3C | |
---- -- | |
L3E | |
L1D | |
Proctor Heyman LLPLocal | L3E |
L1D | |
L3E | |
L5E | |
L5E | |
L5E | |
L4B | |
L3D | |
L2B | |
---- -- | |
Rivkin Radler LLPLocal | L2C |
L3B | |
L1C | |
L2C | |
L5D | |
L2D | |
L5E | |
L5E | |
L4B | |
L4E | |
L3E | |
---- -- | |
L2E | |
L5D | |
L5E | |
L5E | |
L4E | |
L1D | |
---- -- | |
---- -- | |
---- -- | |
---- -- | |
---- -- | |
---- -- | |
Attorney at LawLocal | ---- -- |
---- -- |